Simulations Plus, Inc.
Simulations Plus, Inc. provides software and consulting services for drug discovery, development, clinical trial operations, and commercialization. Its modeling and simulation tools help pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory organizations, assess… From the company’s description.
Over the twelve months to May 31, 2026, Simulations Plus, Inc. reported revenue of $82.06M, up 2.1% from a year earlier, and net income of $8.11M. Its operating margin was 14.0%, and operations generated $24.94M in cash. In fiscal 2025, it reported revenue of $79.18M, up 13.1% from fiscal 2024, and a net loss of $64.72M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Simulations Plus, Inc. does
In the company’s own words
Simulations Plus, Inc. provides software and consulting services for drug discovery, development, clinical trial operations, and commercialization. Its modeling and simulation tools help pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory organizations, assess drug properties, inform dosing and formulation, design clinical trials, and support regulatory submissions and product launches. Software includes ADMET Predictor for AI- and machine-learning-based molecular property predictions, GastroPlus for drug absorption and pharmacokinetic simulations, DILIsym for liver-injury modeling, MonolixSuite for population modeling and clinical trial simulation, and Pro-ficiency for clinical trial training. Consulting spans pharmacokinetic and pharmacodynamic, physiologically based pharmacokinetic, and quantitative systems pharmacology modeling, as well as clinical operations and medical communications. The company reports two principal revenue categories: software, which accounted for 58% of fiscal 2025 revenue, and services, which accounted for 42%. It employed 213 people as of August 31, 2025. Its website is www.simulations-plus.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Business Services & Software
- Headquarters
- DURHAM, NC
- Fiscal year end
- August
- CIK
- 1023459
- SIC
- 7373
Financial performance, year by year
Fiscal 2012–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Simulations Plus, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Simulations Plus, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Simulations Plus, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Simulations Plus, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Simulations Plus, Inc.'s last four quarterly filings that the numbers alone won't show?”